11-8937981-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020646.3(ASCL3):c.181G>A(p.Asp61Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,613,830 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020646.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000132 AC: 20AN: 152046Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251382Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135870
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461784Hom.: 0 Cov.: 66 AF XY: 0.0000124 AC XY: 9AN XY: 727178
GnomAD4 genome AF: 0.000132 AC: 20AN: 152046Hom.: 1 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74282
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.181G>A (p.D61N) alteration is located in exon 2 (coding exon 1) of the ASCL3 gene. This alteration results from a G to A substitution at nucleotide position 181, causing the aspartic acid (D) at amino acid position 61 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at